{
    "2021-02-03": [
        [
            {
                "time": "2021-02-04",
                "original_text": "Novo Nordisk A/S to Host Earnings Call",
                "features": {
                    "keywords": [
                        "earnings call",
                        "Novo Nordisk"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2021-02-04",
                "original_text": "Novo Nordisk (NVO) Q4 Earnings and Sales Beat Estimates",
                "features": {
                    "keywords": [
                        "Q4 earnings",
                        "sales beat",
                        "estimates"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2021-02-04",
                "original_text": "Novo Nordisk: Q4 Earnings Insights",
                "features": {
                    "keywords": [
                        "Q4 earnings",
                        "insights"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2021-02-04",
                "original_text": "Diabetes drugmaker Novo Nordisk upbeat on 2021, sees Biden boost",
                "features": {
                    "keywords": [
                        "diabetes drugmaker",
                        "upbeat",
                        "Biden boost"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2021-02-04",
                "original_text": "Novo Nordisk's net profit increased by 8% in 2020",
                "features": {
                    "keywords": [
                        "net profit",
                        "increased",
                        "2020"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}